Metabolic and systemic heart diseases represent a complex intersection of multiple physiological systems, where conditions such as diabetes, obesity, and hypertension can significantly impact cardiovascular health. These systemic diseases often lead to changes in heart function, contributing to conditions like heart failure, coronary artery disease, and arrhythmias. Understanding the links between metabolic imbalances and cardiovascular outcomes is crucial for developing effective treatment strategies. Metabolic and systemic heart diseases require a multidisciplinary approach that combines pharmacological interventions, lifestyle modifications, and targeted therapies to address the root causes. By focusing on managing underlying metabolic conditions, healthcare providers can significantly reduce the risk of heart-related complications and improve long-term cardiovascular health.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China